| The changing nature of communication and regulation of risk in Europe R Lofstedt, F Bouder, J Wardman, S Chakraborty Journal of Risk Research 14 (4), 409-429, 2011 | 102 | 2011 |
| Risk communication and the pharmaceutical industry B Edwards, S Chakraborty Drug safety 35 (11), 1027-1040, 2012 | 30 | 2012 |
| How risk perceptions, not evidence, have driven harmful policies on COVID-19 S Chakraborty European Journal of Risk Regulation 11 (2), 236-239, 2020 | 27 | 2020 |
| The future of risk communication and the role of the pharmaceutical industry S Chakraborty, F Bouder Current drug safety 8 (1), 4-10, 2013 | 15 | 2013 |
| Transparency Initiative by the FDA’s Center for Drug Evaluation and Research (CDER): Two qualitative studies of Public Perceptions S Chakraborty, R Lofstedt European Journal of Risk Regulation 3 (1), 57-71, 2012 | 15 | 2012 |
| Part I: The role of trust in patient noncompliance: a qualitative case study of users of statins for the chronic treatment of high-cholesterol in New York City S Chakraborty Journal of Risk Research 16 (1), 97-112, 2013 | 12 | 2013 |
| Transparency and the Food and Drug Administration—A quantitative study R Lofstedt, F Bouder, S Chakraborty Journal of health communication 18 (4), 391-396, 2013 | 11 | 2013 |
| Part II: the role of trust in patient noncompliance: a quantitative case study of users of statins for the chronic treatment of high cholesterol in New York City S Chakraborty Journal of Risk Research 16 (1), 113-129, 2013 | 7 | 2013 |
| Predictably irrational consumer food preferences J Bobo, S Chakraborty European Journal of Risk Regulation 7 (3), 604-609, 2016 | 6 | 2016 |
| Risk communication and transparency: a quantitative study R Löfstedt, F Bouder, S Chakraborty Journal of Health Communication: International Perspectives 18 (4), 391-396, 2013 | 6 | 2013 |
| Pink slime, raw milk and the tweetification of risk J Bobo, S Chakraborty European Journal of Risk Regulation 6 (1), 141-144, 2015 | 5 | 2015 |
| The changing nature of regulation and communication of risk in Europe R Löfstedt, F Bouder, JK Wardman, S Chakraborty Journal of Risk Research 14 (4), 409-429, 2011 | 5 | 2011 |
| Challenges and opportunities of omnichannel retailing S Chakraborty, I Chung European Journal of Risk Regulation 5 (3), 386-388, 2014 | 4 | 2014 |
| 2010 Meltdown–Airport Closure Risk Communications in London and NYC S Chakraborty, N Creutzfeldt-Banda European Journal of Risk Regulation 2 (1), 108-110, 2011 | 4 | 2011 |
| The challenge of emergency risk communication: lessons learned in trust and risk communication from the volcanic ash crisis S Chakraborty The challenges of emergency risk regulation. Cheltenham and Northampton …, 2011 | 4 | 2011 |
| Risk and crisis communication recommendations for industry based on advances in cognitive behavioral science research S Chakraborty European Journal of Risk Regulation 5 (2), 238-241, 2014 | 3 | 2014 |
| The Risk vs hazard debate: reconciling inconsistencies in health & safety regulation within the UK and across the EU S Chakraborty | 3 | 2012 |
| Pharmaceutical and medical device safety: a study in public and private regulation S Macleod, S Chakraborty Bloomsbury Publishing, 2019 | 2 | 2019 |
| Pink Slime versus Garbage Chic: A Consideration of the Impact of Framing on Consumer Behavior Towards Food Waste J Bobo, S Chakraborty European Journal of Risk Regulation 6 (3), 445-447, 2015 | 2 | 2015 |
| Transparency and the food and drug administration-A quantitative study R Löfstedt, F Bouder, S Chakraborty Journal of Health Communication: International Perspectives 18 (4), 391-396, 2013 | 2 | 2013 |
